Galmed Pharmaceuticals Ltd. (NASDAQ: GLMD) ("Galmed" or the "Company"), a clinical-stage biopharmaceutical company for liver, cardiometabolic diseases and GI oncological therapeutics, announced today ...

The organization’s long-term direction and guiding principles are outlined in its vision statement, which details its commitment to transforming ideas into scalable and strategically aligned products.

A new generation of interactive formulation development platforms can leave trial and error in the formulation process in the past. Development of any new drug ...

LNPs continue to dominate the spotlight in biopharma with three landmark acquisitions in the past six months, AbbVie/Capstan Therapeutics, Eli Lilly and Co/Verve Therapeutics and Bristol Myers ...

Crystal Pharmatech is a science-driven CRO/CDMO specializing in solid-state research, preformulation studies, and formulation development and manufacturing for small molecule drugs. The company ...

The Ondo State Oil Producing Areas Development Commission (OSOPADEC) has stepped up efforts to drive inclusive development by ...

Manufacturing Agreement Advances Metformin Ophthalmology Platform Toward First-in-Human Clinical Study. Palm Beach Gardens, FL, April 15, 2026 (GLOBE NEWSWIRE) -- Curative Biotech ...

Emalex Biosciences received a patent covering an orally disintegrating tablet (ODT) formulation of ecopipam, an ...

Discover what automation means for industry capability in 2026, including key benefits and emerging technologies.

Vitaquest International LLC, a leading U.S. contract manufacturer of dietary supplements and nutraceuticals, released its Fall 2026 Dietary Supplement Trends Report, identifying the key categories and ...

Lonza AG (Basel, Switzerland), one of the world’s largest contract development and manufacturing organizations (CDMOs), ...

Overview of the RoleIndigo Brands, part of AVI Limited, is offering an exciting opportunity for a Formulation Intern at its ...